Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

ClinicalTrials.gov ID: NCT00613002

Public ClinicalTrials.gov record NCT00613002. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of the Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a randomized, double-blind, placebo-controlled, multi-center study of the safety and efficacy of LibiGel® 300mcg in the treatment of HSDD in surgically menopausal women

Study identification

NCT ID
NCT00613002
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
BioSante Pharmaceuticals
Industry
Enrollment
597 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 65 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2006 (Type not available)
Primary completion
Sep 2011 (Actual)
Completion
Sep 2011 (Actual)
Last update posted
Jan 10, 2013

2006 – 2011

United States locations

U.S. sites
60
U.S. states
30
U.S. cities
59
Facility City State ZIP Site status
BioSante Site #215 Birmingham Alabama 35209 —
BioSante Site #095 Hoover Alabama 35216 —
BioSante Site #014 Huntsville Alabama 35801 —
BioSante Site #027 Glendale Arizona 85308 —
BioSante Site #040 Tucson Arizona 85715 —
BioSante Site #052 Hot Springs Arkansas 71913 —
BioSante Site #182 Buena Park California 90620 —
BioSante Site #008 San Diego California 92108 —
BioSante Site #007 Denver Colorado 80218 —
BioSante Site #216 Denver Colorado 80239 —
BioSante Site #036 Ridgefield Connecticut 06877 —
BioSante Site #013 Washington D.C. District of Columbia 20036 —
BioSante Site #024 Miami Florida 33126 —
BioSante Site #219 Pinellas Park Florida 33781 —
BioSante Site #041 St. Petersburg Florida 33709 —
BioSante Site #009 West Palm Beach Florida 33409 —
BioSante Site #189 Addison Illinois 60101 —
BioSante Site #005 Shreveport Louisiana 71115 —
BioSante Site #004 Baltimore Maryland 21285 —
BioSante Site #044 Detroit Michigan 48201 —
BioSante Site #047 Grand Rapids Michigan 49503 —
BioSante Site #033 Saginaw Michigan 48604 —
BioSante Site #031 Saint Clair Shores Michigan 48081 —
BioSante Site #208 Edina Minnesota 55435 —
BioSante Site #198 Saint Paul Minnesota 55108 —
BioSante Site #051 Missoula Montana 59808 —
BioSante Site #006 Lincoln Nebraska 68501 —
BioSante Site #217 Las Vegas Nevada 89146 —
BioSante Site #015 Poughkeepsie New York 12601 —
BioSante Site #059 Cary North Carolina 27518 —
BioSante Site #079 Charlotte North Carolina 28209 —
BioSante Site #061 Winston-Salem North Carolina 27103 —
BioSante Site #056 Fargo North Dakota 58103 —
BioSante Site #210 Akron Ohio 44311 —
BioSante Site #212 Cincinnati Ohio 45249 —
BioSante Site #213 Columbus Ohio 43212 —
BioSante Site #050 Eugene Oregon 97401 —
BioSante Site #197 Wexford Pennsylvania 15090 —
BioSante Site #089 Columbia South Carolina 29201 —
BioSante Site #209 Greer South Carolina 29651 —
BioSante Site #097 Hilton Head Island South Carolina 29926 —
BioSante Site #038 Mt. Pleasant South Carolina 29464 —
BioSante Site #049 Watertown South Dakota 57201 —
BioSante Site #093 Bristol Tennessee 37620 —
BioSante Site #069 Chattanooga Tennessee 37404 —
BioSante Site #078 Memphis Tennessee 38120 —
BioSante Site #042 Nashville Tennessee 37203 —
BioSante Site #048 Austin Texas 78705 —
BioSante Site #073 Corpus Christi Texas 78414 —
BioSane Site #220 Dallas Texas 75231 —
BioSante Site #039 Houston Texas 77054 —
BioSante Site #211 San Antonio Texas 78229 —
BioSante Site #218 Murray Utah 84123 —
BioSante Site #096 Williston Vermont 05495 —
BioSante Site #003 Charlottesville Virginia 22903 —
BioSante Site #086 Norfolk Virginia 23502 —
BioSante Site #053 Richmond Virginia 23294 —
BioSante Site #090 Virginia Beach Virginia 23456 —
BioSante Site #083 Mountlake Terrace Washington 98043 —
BioSante Site #181 Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00613002, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2013 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00613002 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →